The physics of radiofrequency ablation vs cryoablation for renal cell carcinoma.Cryoablative technology and radiofrequency ablative ablative (ăb`lətĭv') [Lat.,=carrying off], in Latin grammar, the case used in a number of circumstances, particularly with certain prepositions and in locating place or time. The term is also used in the grammar of some languages (e.g. technology are both used for percutaneous image guided renal cell carcinoma renal cell carcinoma or hypernephroma Malignant tumour of the cells that cover and line the kidney. It usually affects persons over age 50 who have vascular disorders of the kidneys. It seldom causes pain, unless it is advanced. ablation. The physics of these procedures determines which is better suited for achieving complete tumor necrosis tumor necrosis Death of tumor tissue, a common event in aggressive CAs in which the tumor rapidly outgrows its blood supply, resulting in tumor cell death. Cf Apoptosis. . Review of the current literature regarding the results of using radiofrequency ablation Radiofrequency ablation (RFA) A technique for removing a tumor by heating it with a radiofrequency current passed through a needle electrode. Mentioned in: Liver Cancer, Prenatal Surgery for renal cell carcinoma is compared with this institution's 5-year experience with cryoablation of renal cell carcinoma under MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. guidance. Treatment success rates, tumor site, tumor location, complication rates, and recurrent or residual disease residual disease Oncology Malignant cells or neoplasia that remains after any form–chemotherapy, surgery, RT–of 1º treatment are all evaluated in an effort to distinguish which of these methods is more effective for the treatment of renal cell carcinoma with minimally invasive image guided thermal ablative technologies. Additionally, an explanation of the physics of both thermal ablative technologies at the cellular level is included in an effort to provide an understanding of the abilities and limitations of these technologies in the treatment of this disease process. Review of the literature suggests that both technologies are suitable for treating a subset of renal cell carcinomas: exophytic tumors less than 3 cm in size. However, as the tumor size increases above 3 cm and as the tumor location moves centrally, treatment success rate with a single therapy intervention and multiple therapeutic interventions is greater with cryoablation when compared to radiofrequency ablation. Additionally, the image-guided superiority of MRI plays a role in the treatment success rate when compared to ultrasound or CT guided radiofrequency ablation of renal cell carcinoma. Cryoablation for renal cell carcinoma is better than radiofrequency ablation for achieving complete tumor necrosis. MRI for image guidance increases the success rate and decreases the complications. Patrick E. Sewell, Jr. MD. Department of Radiology, Division of Interventional Oncology, University of Mississippi Medical Center University of Mississippi Medical Center (UMC) is the health sciences campus of the University of Mississippi (Ole Miss). Located in Jackson, Mississippi (USA), it houses the Schools of Medicine, Dentistry, Nursing, Health Related Professions, and Graduate Studies in the Health , Jackson, MS. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion